Literature DB >> 1281977

Purification and structure of human liver aspartylglucosaminidase.

J W Rip1, M B Coulter-Mackie, C A Rupar, B A Gordon.   

Abstract

We have recently diagnosed aspartylglucosaminuria (AGU) in four members of a Canadian family. AGU is a lysosomal storage disease in which asparagine-linked glycopeptides accumulate to particularly high concentrations in liver, spleen and thyroid of affected individuals. A lesser accumulation of these glycopeptides is seen in the kidney and brain, and they are also excreted in the urine. The altered metabolism in AGU results from a deficiency of the enzyme aspartylglucosaminidase (1-aspartamido-beta-N-acetylglucosamine amidohydrolase), which hydrolyses the asparagine to N-acetylglucosamine linkages of glycoproteins and glycopeptides. We have used human liver as a source of material for the purification of aspartylglucosaminidase. The enzyme has been purified to homogeneity by using heat treatment, (NH4)2SO4 fractionation, and chromatography on concanavalin A-Sepharose, DEAE-Sepharose, sulphopropyl-Sephadex, hydroxyapatite, DEAE-cellulose and Sephadex G-100. Enzyme activity was followed by measuring colorimetrically the N-acetylglucosamine released from aspartylglucosamine at 56 degrees C. The purified enzyme protein ran at a 'native' molecular mass of 56 kDa in SDS/12.5%-PAGE gels, and the enzyme activity could be quantitatively recovered at this molecular mass by using gel slices as enzyme source in the assay. After denaturation by boiling in SDS the 56 kDa protein was lost with the corresponding appearance of polypeptides alpha,beta and beta 1, lacking enzyme activity, at 24.6, 18.4 and 17.4 kDa respectively. Treatment of heat-denatured enzyme with N-glycosidase F resulted in the following decreases in molecular mass; 24.6 to 23 kDa and 18.4 and 17.4 to 15.8 kDa. These studies indicate that human liver aspartylglucosaminidase is composed of two non-identical polypeptides, each of which is glycosylated. The N-termini of alpha,beta and beta 1 were directly accessible for sequencing, and the first 21, 26 and 22 amino acids respectively were identified.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281977      PMCID: PMC1131987          DOI: 10.1042/bj2881005

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  Human leucocyte aspartylglucosaminidase. Evidence for two different subunits in a more complex native structure.

Authors:  R Halila; M Baumann; E Ikonen; N Enomaa; L Peltonen
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Purification and some properties of 1-aspartamido-beta-N-acetylglucosamine amidohydrolase from human liver.

Authors:  B Dugal; J Stromme
Journal:  Biochem J       Date:  1977-09-01       Impact factor: 3.857

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Cloning and sequence analysis of a cDNA for human glycosylasparaginase. A single gene encodes the subunits of this lysosomal amidase.

Authors:  K J Fisher; O K Tollersrud; N N Aronson
Journal:  FEBS Lett       Date:  1990-09-03       Impact factor: 4.124

5.  Effect of different compounds on 1-aspartamido-beta-N-acetylglucosamine amidohydrolase from human liver.

Authors:  B Dugal
Journal:  Biochem J       Date:  1978-06-01       Impact factor: 3.857

6.  Aspartylglycosaminuria in Northern Norway in eight patients: clinical heterogeneity and variations with the diet.

Authors:  O Borud; J H Strömme; S O Lie; K H Torp
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

7.  Detection of heterozygotes for aspartylglucosaminuria (AGU) in cultured fibroblasts.

Authors:  P Aula; S Autio; K Raivio; V Näntö
Journal:  Humangenetik       Date:  1974

8.  Aspartylglucosaminuria in the United States.

Authors:  S Hreidarsson; G H Thomas; D L Valle; R E Stevenson; H Taylor; J McCarty; S B Coker; W R Green
Journal:  Clin Genet       Date:  1983-06       Impact factor: 4.438

9.  Purification and characterization of rat liver glycosylasparaginase.

Authors:  O K Tollersrud; N N Aronson
Journal:  Biochem J       Date:  1989-05-15       Impact factor: 3.857

10.  Aspartylglucosaminuria in a Puerto Rican family: additional features of a panethnic disorder.

Authors:  D Chitayat; S Nakagawa; R W Marion; G S Sachs; S Y Hahm; H S Goldman
Journal:  Am J Med Genet       Date:  1988-11
View more
  2 in total

1.  Human leucocyte glycosylasparaginase is an alpha/beta-heterodimer of 19 kDa alpha-subunit and 17 and 18 kDa beta-subunit.

Authors:  O K Tollersrud; T Heiskanen; L Peltonen
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

2.  Biochemical characterization and comparison of aspartylglucosaminidases secreted in venom of the parasitoid wasps Asobara tabida and Leptopilina heterotoma.

Authors:  Quentin Coulette; Séverine Lemauf; Dominique Colinet; Geneviève Prévost; Caroline Anselme; Marylène Poirié; Jean-Luc Gatti
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.